SIA Swixx BiopharmaActive
Key figures
Ratios
2025Balance sheet structure
Summary of financial statements2015–2025
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Balance sheet — assets | |||||||||||
| Total current assets | 23 037 | 23 457 | 40 972 | 48 693 | 83 823 | 78 047 | 97 861 | 356 563 | 554 851 | 735 504 | 965 285 |
| Total non-current assets | 2817 | 2994 | 2898 | 2863 | 2490 | 2919 | 36 609 | 39 085 | 31 927 | 49 843 | 33 904 |
| Total assets | 25 854 | 26 451 | 43 870 | 51 556 | 86 313 | 80 966 | 134 470 | 395 648 | 586 778 | 785 347 | 999 189 |
| Balance sheet — liabilities and equity | |||||||||||
| Current liabilities | 6036 | 10 876 | 8918 | 10 786 | 37 060 | 20 634 | 59 125 | 28 169 | 22 959 | 292 354 | 290 950 |
| Non-current liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total liabilities | 6036 | 10 876 | 8918 | 10 786 | 37 060 | 20 634 | 59 125 | 28 169 | 22 959 | 292 354 | 290 950 |
| Share capital | — | — | — | — | — | — | — | — | — | — | — |
| Retained earnings of previous periods | — | — | — | — | — | — | — | — | — | — | — |
| Profit for the year | 17 018 | -4243 | 16 360 | 5818 | 8483 | 11 079 | 15 013 | 117 375 | 141 836 | 145 777 | 215 246 |
| Total equity | 19 818 | 15 575 | 34 952 | 40 770 | 49 253 | 60 332 | 75 345 | 192 720 | 347 215 | 492 993 | 708 239 |
| Income statement | |||||||||||
| Sales revenue | 45 959 | 201 016 | 220 093 | 257 312 | 334 480 | 347 615 | 524 163 | 2 712 434 | 2 993 575 | 2 990 693 | 3 004 571 |
| Operating profit | 20 035 | -4243 | 20 079 | 7150 | 9837 | 12 245 | 16 542 | 154 551 | 181 048 | 177 143 | 262 115 |
| Profit before income tax | 20 035 | -4243 | 20 079 | 7150 | 9837 | 12 245 | 16 542 | 154 551 | 181 048 | 177 143 | 262 115 |
| Profit for the reporting year | 17 018 | -4243 | 16 360 | 5818 | 8483 | 11 079 | 15 013 | 117 375 | 141 836 | 145 777 | 215 246 |
| Labour costs | — | — | — | — | — | — | — | — | — | — | — |
| Depreciation of non-current assets | — | — | — | — | — | — | — | — | — | — | — |
| Other indicators | |||||||||||
| Employees | 1 | 2 | 2 | 2 | 3 | 3 | 3 | 22 | 23 | 23 | 22 |
| Calculated dividend | — | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
A dash (—) means the report has not been filed or the line is not reported; 0 is a zero stated in the report.
Connections graph
Related companies
Summary: SIA Swixx Biopharma
Overview
SIA Swixx Biopharma (reg. no. 40103845472) is a limited liability company. The company was registered in 2014 and has been in the register for 11 years. Registered address: Rīga, Krišjāņa Valdemāra iela 33A - 8A.
Financial results
Revenue in 2025 was 3 004 571 €, on a par with the previous year. From 2015 to 2025, revenue grew by an average of 51,9% per year. This is the company's highest revenue among the published years (2015–2025). Net profit for 2025 was 215 246 € (7,2% of revenue). The company was profitable in 10 of the 11 published years. In 2025 the company had 22 employees (23 a year earlier). Revenue per employee was 136 571 €. At the end of 2025, total assets were 999 189 € and equity 708 239 € (70,9% of assets).
Management and owners
The board has 4 members. The sole owner of the company is Swixx Biopharma AG.
Data sources and freshness
Register data (name, address, legal form, board and owners) and annual report figures come from the open data of the Register of Enterprises of the Republic of Latvia (CC0); entity.lv updates them daily. Data as of 03.11.2026. Changes, averages and ratios are calculated by entity.lv from open data and are not an official assessment.